News

April 3, 2018

PLANNED MAINTENANCE TO ESERVICES AND RELATED SERVICES ON APRIL 6 and 7

Required maintenance work to the College’s IT systems supporting eServices will take place between 5:00 pm on Friday, April 6 to 6:00 pm on Saturday, April 7. 

March 7, 2018

OPIOID AGONIST TREATMENT ALERT SLOW RELEASE ORAL MORPHINE SHORTAGE RESOLVED UPDATE:
February 27, 2018 

From The British Columbia Centre on Substance Use

February 28, 2018

New election cycle and term of office for elected Board members are now in effect and will be implemented for the November 2018 election.

 
February 28, 2018

Dr. Finlay Morrison passed away peacefully on the morning of December 28, 2017 at the age of 100 years- a birthday that he celebrated just two weeks prior on December 15 with family and friends.

February 20, 2018

The College is now recruiting volunteers to serve on its committees

Deadline for Application is Friday, March 16, 2018 at 5:00PM

February 16, 2018

The highlights from the February Board Meeting are now available.

February 9, 2018

Amendments to the Pharmacy Operations and Drug Scheduling Act (PODSA) permit the College to know the identity of all pharmacy owners, determine their suitability for pharmacy ownership and hold them accountable for providing safe and effective care by ensuring their pharmacies are compliant with legislative requirements for pharmacies in BC.

While these amendments were originally slated...

January 11, 2018

Tracey Hagkull and Justin Thind have been appointed by Minister of Health, Adrian Dix, to serve as public board members for a term of two years. Ryan Hoag has been appointed for...

January 10, 2018

Opioid Agonist Treatment Alert: Potential Slow Release Oral Morphine Shortage

From The British Columbia Centre on Substance Use

 

January 2, 2018

On January 1, 2018, amendments to Professional Practice Policy – 66, including changing its name from “Methadone Maintenance Treatment” to “Opioid Agonist Treatment,” came into effect. These amendments also include the introduction of new policy guides for buprenorphine/naloxone, and slow-release oral morphine​.

 

Pages